SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations

The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia

(2009) Lars Klemm et al.   CANCER CELL

Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy

(2009) D. Nowak et al.   HAEMATOLOGICA

No significance of derivative chromosome 9 deletion on the clearance kinetics ofBCR/ABLfusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia

(2008) Dong Hwan (Dennis) Kim et al.   CANCER

Imatinib resistance in CML

(2008) Gisella Volpe et al.   CANCER LETTERS

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

(2008) J S Khorashad et al.   LEUKEMIA

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

(2008) Charles G. Mullighan et al.   NATURE

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray

(2007) N. Kawamata et al.   BLOOD